Old Web
English
Sign In
Acemap
>
authorDetail
>
Paul Burgess
Paul Burgess
GlaxoSmithKline
Eltrombopag
Medicine
Immunology
Adverse effect
Placebo
6
Papers
81
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Update On The Safety and Efficacy Of EXTENDed Treatment With Eltrombopag (EPAG) In Adults With Chronic Immune Thrombocytopenia (ITP)
2013
Blood
Mansoor N. Saleh
Raymond Siu Ming Wong
Paul Burgess
Kalpana Bakshi
Geoffrey Chan
Christine K Bailey
Show All
Source
Cite
Save
Citations (6)
Long-Term Safety and Efficacy of Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP): Report of up to 5.5 Years of Treatment in EXTEND.
2012
Blood
Mansoor N. Saleh
Gregory Cheng
James B. Bussel
Paul Burgess
Kalpana Bakshi
Andres Brainsky
Christine K Bailey
Show All
Source
Cite
Save
Citations (2)
1